ES1302428U - Nutritional supplement (Machine-translation by Google Translate, not legally binding) - Google Patents
Nutritional supplement (Machine-translation by Google Translate, not legally binding) Download PDFInfo
- Publication number
- ES1302428U ES1302428U ES202231842U ES202231842U ES1302428U ES 1302428 U ES1302428 U ES 1302428U ES 202231842 U ES202231842 U ES 202231842U ES 202231842 U ES202231842 U ES 202231842U ES 1302428 U ES1302428 U ES 1302428U
- Authority
- ES
- Spain
- Prior art keywords
- translation
- machine
- legally binding
- google translate
- nutritional supplement
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
DESCRIPCIÓNDESCRIPTION
Suplemento alimenticioNutritional supplement
SECTOR DE LA TÉCNICATECHNIQUE SECTOR
La presente invención se refiere a un suplemento alimenticio, destinado a atrapar las grasas de los alimentos impidiendo su absorción y promoviendo su eliminación a través de las heces.The present invention refers to a food supplement, intended to trap fats in food, preventing their absorption and promoting their elimination through feces.
El objeto de la invención es por tanto ofrecer un producto capaz de neutralizar las grasas según discurren junto al bolo alimenticio con posteridad a su aprovechamiento metabólico.The object of the invention is therefore to offer a product capable of neutralizing fats as they flow together with the food bolus after its metabolic use.
Se trata de un producto que aporta sensación de saciedad y aumenta el volumen fecal.It is a product that provides a feeling of satiety and increases fecal volume.
ANTECEDENTES DE LA INVENCIÓNBACKGROUND OF THE INVENTION
En el ámbito de aplicación práctica de la invención, se conocen infinidad de suplementos alimenticios con el fin de adelgazar, de manera que si bien algunos de los componentes que participan en el suplemento de la invención son conocidos de forma aislada por sus propiedades adelgazantes, no se conoce un producto en el que participe una mezcla de componentes como la que seguidamente se va a describir.In the field of practical application of the invention, an infinite number of food supplements are known for the purpose of losing weight, so that although some of the components that participate in the supplement of the invention are known in an isolated way for their slimming properties, they are not A product is known in which a mixture of components such as the one that will be described below participate.
EXPLICACIÓN DE LA INVENCIÓNEXPLANATION OF THE INVENTION
El suplemento que se preconiza se materializa en una fibra muy soluble, que posee una excepcional capacidad de captar agua, formando soluciones muy viscosas. Posee un peso molecular y una viscosidad más elevados que cualquier fibra conocida.The recommended supplement is materialized in a highly soluble fiber, which has an exceptional capacity to capture water, forming highly viscous solutions. It has a higher molecular weight and viscosity than any known fiber.
Para ello, y de forma más concreta, el suplemento alimenticio de la invención presenta la siguiente composición en % en peso:For this, and more specifically, the food supplement of the invention has the following composition in % by weight:
• Glucomanano de konjac (Amorphophallus konjac) entre el 35 y el 42%.• Glucomannan from konjac (Amorphophallus konjac) between 35 and 42%.
• Extracto seco de tamarindo (Tamarindus indica)....... entre el 13 y el 19%. • Dry extract of tamarind (Tamarindus indica)........ between 13 and 19%.
Chitosán...................... entre el 13 y el 19% Aglutinante.................... .entre el 8 y el 11%.Chitosan.......................... between 13 and 19% Binder...... ..between 8 and 11%.
Antiaglomerante........... entre el 8 y el 11%.Anti-caking agent.......... between 8 and 11%.
Estabilizante espesante .entre el 8 y el 11%.Thickener stabilizer between 8 and 11%.
El empleo de konjac supone incluir en el suplemento una fibra saciante con un alto contenido en polisacáridos de tipo glucomanano, no digerible por nuestro organismo, provocando de esta forma sensación de saciedad y disminución del apetito.The use of konjac means including in the supplement a satiating fiber with a high content of glucomannan-type polysaccharides, indigestible by our body, thus causing a feeling of satiety and decreased appetite.
Por su parte, el tamarindo es un fruto rico en proteínas, lípidos, y sobre todo, polisacáridos, que tienen actividad laxante, antioxidante e hipoglucemiante.For its part, tamarind is a fruit rich in proteins, lipids, and above all, polysaccharides, which have laxative, antioxidant and hypoglycemic activity.
En cuanto al chitosán, este producto también tiene un efecto saciante, debido a la fibra alimentaria del chitosano.As for chitosan, this product also has a satiating effect, due to the dietary fiber of chitosan.
EJEMPLO DE REALIZACIÓN PRÁCTICA DE LA INVENCIÓNEXAMPLE OF PRACTICAL PERFORMANCE OF THE INVENTION
A modo meramente ejemplario, para obtener una dosis de 1086 mg de suplemento alimenticio de la invención se utilizaron los siguientes componentes:By way of example, to obtain a 1086 mg dose of the food supplement of the invention, the following components were used:
• Glucomanano de konjac (Amorphophallus konjac)....420 mg.• Glucomannan from konjac (Amorphophallus konjac)....420 mg.
• Extracto seco de tamarindo (Tamarindus indica)........174 mg.• Dry extract of tamarind (Tamarindus indica)........174 mg.
• Chitosán.....................................................................174mg.• Chitosan.................................................. ......................174mg.
• Aglutinante..................................................................106 mg.• Binder................................................... ..................106mg.
• Antiaglomerante.........................................................106 mg.• Anti-caking agent................................................ .........106mg.
• Estabilizante espesante..............................................106 mg.• Stabilizer thickener............................................106 mg.
El producto así descrito se suministra en cápsulas de 1086 mg, recomendándose una dosis diaria de 6 cápsulas.The product thus described is supplied in 1086 mg capsules, recommending a daily dose of 6 capsules.
La elevada capacidad de absorción de agua que posee estesuplemento alimenticio hace que éste se hinche en el estómago, proporcionando sensación de saciedad, y debido a su capacidad de aumentar la viscosidad del contenido gastrointestinal retrasa el vaciado gástrico, prolongando así el efecto de plenitud. Dadas estas acciones, que contribuyen a reducir el apetito.The high water absorption capacity of this food supplement causes it to swell in the stomach, providing a feeling of satiety, and due to its ability to increase the viscosity of the gastrointestinal content, it delays emptying. stomach, thus prolonging the fullness effect. Given these actions, they contribute to reducing appetite.
Experimentalmente se ha comprobado que el consumo de esta fibra contribuye a normalizar el ritmo de evacuación intestinal y favorece la producción de heces blandas y voluminosas.Experimentally it has been verified that the consumption of this fiber helps to normalize the rhythm of intestinal evacuation and favors the production of soft and bulky stools.
Estos efectos se deben a que el producto de la invención incrementa el volumen de las heces, principalmente a expensas del aumento de la masa bacteriana que se produce en el colon.These effects are due to the fact that the product of the invention increases the volume of feces, mainly at the expense of the increase in bacterial mass that occurs in the colon.
Solo resta señalar por último que, esta fibra no limita laabsorción de minerales como el calcio, el hierro, elcobre o el zinc. Finally, it only remains to point out that this fiber does not limit the absorption of minerals such as calcium, iron, copper or zinc.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES202231842U ES1302428Y (en) | 2022-11-08 | 2022-11-08 | Nutritional supplement |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES202231842U ES1302428Y (en) | 2022-11-08 | 2022-11-08 | Nutritional supplement |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES1302428U true ES1302428U (en) | 2023-07-31 |
| ES1302428Y ES1302428Y (en) | 2023-10-20 |
Family
ID=87427919
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES202231842U Expired - Fee Related ES1302428Y (en) | 2022-11-08 | 2022-11-08 | Nutritional supplement |
Country Status (1)
| Country | Link |
|---|---|
| ES (1) | ES1302428Y (en) |
-
2022
- 2022-11-08 ES ES202231842U patent/ES1302428Y/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ES1302428Y (en) | 2023-10-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Di Bartolomeo et al. | Prebiotics to fight diseases: reality or fiction? | |
| ES2874273T3 (en) | GOS and polyfructose synergism | |
| ES2904608T3 (en) | Fucosyl lactose as a non-digestible oligosaccharide identical to that of breast milk to treat and/or prevent viral diarrhea | |
| CN103300278B (en) | Composition comprising imidazole peptide and quercetin glycoside | |
| CN102008034B (en) | Nutritional meal replacement food for weight loss and laxative | |
| CN104114039A (en) | Extensional viscosity to promote safe swallowing of food boluses | |
| BR112013022060B1 (en) | nutritional product, methods for preparing it and improving its cohesion, and uses of a food grade polymer | |
| PT1887888E (en) | Use of polydextrose for simulating the functional attributes of human milk oligosaccharides in formula-fed infants | |
| HK1222514A1 (en) | Nutritional compositions for enhancing brain development | |
| AR078485A1 (en) | BIFIDOBACTERIUM LONGUM ATCC BAA-999 (BL999) AND WEIGHT CONTROL | |
| JP2013508416A (en) | Stable thickener formulation | |
| Guo et al. | How does carrageenan cause colitis? A review | |
| CN101247735B (en) | nutrition for obese patients | |
| WO2013056048A2 (en) | Nutritional products comprising beta-alanine | |
| Peled et al. | Next-generation prebiotics: Maillard-conjugates of 2′-fucosyllactose and lactoferrin hydrolysates beneficially modulate gut microbiome composition and health promoting activity in a murine model | |
| CN102283342B (en) | Functional total-nutrient liquid food for space flight and preparation method thereof | |
| ES1302428U (en) | Nutritional supplement (Machine-translation by Google Translate, not legally binding) | |
| JP5581129B2 (en) | Obesity prevention / amelioration agent | |
| CN115486545A (en) | Low BCAAs weight-losing and muscle-increasing nutritional powder as well as preparation method and application thereof | |
| Benkeblia et al. | Fructooligosaccharides of edible alliums: occurrence, chemistry and health benefits | |
| Deng et al. | Effects of konjac glucomannan on physicochemical and rheological properties of whole egg liquid and in vitro fermentation of egg curd | |
| Anand et al. | A review on Ayurvedic non-carbohydrate prebiotics | |
| CN101549145A (en) | Nutrient fluid capable of being radio-resistant and reducing side reaction of radiation treatment | |
| Aluko | Bioactive carbohydrates | |
| CN112056567A (en) | Combined fiber with strong water swellability and high water binding force and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| CA1K | Utility model application published |
Ref document number: 1302428 Country of ref document: ES Kind code of ref document: U Effective date: 20230731 |
|
| FG1K | Utility model granted |
Ref document number: 1302428 Country of ref document: ES Kind code of ref document: Y Effective date: 20231016 |
|
| PC1K | Transfer of utility model |
Owner name: JORGE RIVAS JACOME Effective date: 20240521 |
|
| FD1K | Utility model lapsed |
Effective date: 20251230 |